Daniel H Petree's Insider Trades & SAST Disclosures
Daniel H Petree's most recent trade in Sutro Biopharma Inc was a trade of 35,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel H Petree.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Daniel H. Petree | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jun 2023 | 18,409 | 3,856 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jun 2023 | 18,409 | 18,601 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 4,545 | 0 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.36 per share. | 08 Feb 2022 | 4,545 | 12,533 (0%) | 0% | 4.4 | 19,816 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 3,540 | 0 | - | - | Stock Option | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.81 per share. | 08 Feb 2022 | 3,540 | 22,265 (0%) | 0% | 5.8 | 20,567 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,617 | 0 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.36 per share. | 08 Feb 2022 | 2,617 | 15,150 (0%) | 0% | 4.4 | 11,410 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,124 | 0 | - | - | Stock Option | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.81 per share. | 08 Feb 2022 | 2,124 | 18,725 (0%) | 0% | 5.8 | 12,340 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 873 | 0 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.81 per share. | 08 Feb 2022 | 873 | 16,601 (0%) | 0% | 5.8 | 5,072 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 578 | 0 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.81 per share. | 08 Feb 2022 | 578 | 15,728 (0%) | 0% | 5.8 | 3,358 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.36 per share. | 26 Jan 2021 | 4,132 | 7,988 (0%) | 0% | 4.4 | 18,016 | Common Stock |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 4,132 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Daniel H. Petree | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges